| Intervention group (n = 159) | Control group (n = 157) | P |
---|---|---|---|
Age (years), mean ± SD | 68.3 (8.9) | 68.6 (8.6) | .744 |
Male, n (%) | 116 (73.0) | 119 (75.8) | .563 |
Born outside Sweden, n (%) | 10 (6.3) | 11 (7.0) | .798 |
Married or cohabitating, n (%) | 126 (79.2) | 122 (78.2) | .737 |
Educational level, n (%) | Â | Â | .750 |
 Comprehensive school | 56 (35.2) | 60 (38.2) |  |
 Upper secondary school | 43 (27.0) | 37 (23.6) |  |
 Bachelor’s/Master’s degree | 60 (37.7) | 60 (38.2) |  |
Type of CHD, n (%) | Â | Â | .834 |
 STEMI | 46 (28.9) | 48 (30.6) |  |
 Non-STEMI | 48 (30.2) | 43 (27.4) |  |
 Unstable angina | 17 (10.7) | 18 (11.5) |  |
 Chronic angina | 32 (20.1) | 37 (23.6) |  |
 Other reason for PCI | 15 (9.4) | 10 (6.4) |  |
History of CHD, n (%) | 47 (29.6) | 45 (28.7) | .919 |
Unplanned healthcare contact for CVD, preceding year, n (%) | 27 (17.0) | 20 (12.7) | .289 |
Coronary intervention, n (%) | Â | Â | .459 |
 PCI with DES | 126 (79.7) | 110 (72.8) |  |
 Other PCI | 12 (7.6) | 12 (7.9) |  |
 CABG | 10 (6.3) | 15 (9.9) |  |
 None | 10 (6.3) | 14 (9.3) |  |
Comorbidities, n (%) | Â | Â | Â |
 Hypertension | 79 (48.4) | 74 (49.0) | .910 |
 Other CVD | 22 (13.8) | 17 (10.8) | .392 |
 Diabetes | 23 (14.5) | 20 (12.7) | .622 |
 Other comorbidities | 60 (37.7) | 70 (44.6) | .303 |
 No comorbidities | 35 (22.0) | 33 (21.0) | .830 |
Clinical risk factors, n (%) | Â | Â | Â |
 Smoking | 11 (8.0) | 17 (12.6) | .080 |
 Smoking eligible participants, n | 137 | 135 |  |
 Mean LDL-C, mmol/L (SD) | 2.2 (0.8) | 2.3 (0.8) | .909 |
 LDL -C, treatment target reached, n (%) | 55 (39.6) | 58 (41.7) | .714 |
 LDL-C eligible participants, n | 139 | 139 |  |
 Mean SBP mm Hg (SD) | 139.5 (20.6) | 138.1 (19.6) | .526 |
 SBP, treatment target reached, n (%) | 79 (52.3) | 90 (58.1) | .312 |
 Mean DBP, mm Hg (SD) | 76.1 (11.6) | 75.1 (11.7) | .460 |
 BP eligible participants, n | 151 | 155 |  |
Number of drugs prescribed per participant | Â | Â | Â |
 For regular use, mean (SD) | 7.2 (2.4) | 7.3 (2.3) | .871 |
 As needed, mean (SD) | 2.1 (1.2) | 2.1 (1.3) | .899 |
Self-reported adherencea | Â | Â | Â |
 MMAS-8 score (SD) | 7.5 (1.2) | 7.5 (1.0) | .889 |
 MMAS-8 medium or high adherence, n (%) | 132 (93.0) | 137 (91.9) | .744 |
 MMAS-8 eligible participants, n* | 142 | 149 |  |
Beliefs about medicines | Â | Â | Â |
 Mean Necessity score (SD) | 19.0 (3.1) | 19.0 (3.1) | .913 |
 Mean Concern score (SD) | 13.0 (4.9) | 13.1 (5.1) | .884 |
 Mean Necessity-Concerns differential (SD) | 6.0 (5.7) | 5.9 (6.3) | .964 |
BMQ-S attitudinal category | Â | Â | .359 |
 Accepting, n (%) | 79 (51.0) | 82 (53.2) |  |
 Ambivalent, n (%) | 54 (34.8) | 50 (32.5) |  |
 Indifferent, n (%) | 11 (7.1) | 7 (4.5) |  |
 Skeptical, n (%) | 8 (5.2) | 15 (9.5) |  |
HeartQol score | Â | Â | Â |
 Mean HeartQoL physical (SD) | 2.2 (0.8) | 2.2 (0.7) | .926 |
 Mean HeartQoL emotional (SD) | 2.4 (0.7) | 2.3 (0.8) | .178 |
Mean number of days from discharge to randomization (SD) | 116.4 (37.7) | 122.5 (51.0) | .226 |